title: [Analysis of results of drug therapy for symptomatic multiple myeloma].
abstract: Drug therapy for symptomatic multiple myeloma is comparable for both sexes in its effectiveness and safety. A 3-year event-free survival is comparable in men and women; overall survival in men is lower than in women.
authors.forename: L B
authors.initials: LB
authors.lastname: Lysenko
authors.forename: N
authors.initials: N
authors.lastname: Nikolaeva
authors.forename: T F
authors.initials: TF
authors.lastname: Pushkareva
authors.forename: E A
authors.initials: EA
authors.lastname: Kapuza
authors.forename: O N
authors.initials: ON
authors.lastname: Shatokhina
authors.forename: O V
authors.initials: OV
authors.lastname: Kozyuk
authors.forename: V V
authors.initials: VV
authors.lastname: Dmitrieva
authors.forename: T A
authors.initials: TA
authors.lastname: Snezhko
authors.forename: K A
authors.initials: KA
authors.lastname: Novoselova
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012737:Sex Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents